ImmuPharma PLC (LSE:IMM) - Share price - Overview

Stock Report

ImmuPharma PLC IMM

Last Price
GBX29.09

Day Change
1.49|5.40%

As of 24/05/2018
14:08:56 BST | GBX
Minimum 15 Minutes Delay.

Last Close27.60p
Day Range27.00 - 30.60
Mkt Cap38.49Mil
52-Wk Range19.00 - 193.00
Yield %-
ISINGB0033711010
Volume1,399,387
P/E-6.12
P/S2.08
P/CF-0.05

Share Price

Total Returns 23/05/2018

 Chg (%)  
More ...
ImmuPharma PLC-31.00 
FTSE 100 TR GBP5.81
 
Financials
201420152016
More ...
Income Statement
Turnover0.190.080.17
Operating Profit-3.43-4.56-6.59
Net Profit-2.87-3.90-5.32
Reported EPS-3.43-4.40-4.54
Balance Sheet
Current Assets6.152.415.97
Non Current Assets0.930.800.74
Total Assets7.073.216.71
Current Liabilities0.991.240.94
Total Liabilities1.371.521.16
Total Equity5.711.695.55
Cash Flow
Operating Cash Flow-3.25-4.58-7.19
Net Change in Cash0.20-4.470.90

Company Profile

ImmuPharma PLC is a drug discovery and development company. The Company along with its subsidiaries is engaged in the research and development of novel drugs based on peptide therapeutics to treat serious medical conditions including autoimmune diseases.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 01/06/2018

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-109.49
Op Mrgn-39.99
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Executive OfficerMr. Dimitri Dimitriou
Executive Director, President and Chief Scientific OfficerDr Robert Henri Zimmer
Non-Executive DirectorDr Franco Di Muzio
Non-Executive Director, ChairmanMr Timothy Paul McCarthy
Non-Executive DirectorDr. Stephane Robert George Mery
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.